neobookRx
DrugsLevel 4 LocalisationS0ENEEML

Sodium Citrate/ Sodium Lauryl Sulphoacetate/ Sorbitol

CombinationLaxative

Indications

Registered South African indications:

  • Relief of occasional constipation and for use as a bowel cleansing regimen in preparation for X-ray examination and rectoscopy

Contraindications (ZA)

Registered South African contraindications

  • Hypersensitivity to the active ingredients or any of the excipients in this combination product
  • Inherited fructose intolerance

Warnings & precautions

South African recommendations

Caution in the following patient groups

  • Pregnancy
  • Breastfeeding
  • Renal impairment
  • Severe hepatic impairment
  • Elderly

Use in specific conditions

  • Sodium citrate/sodium lauryl sulphoacetate/sorbitol should not be used in the presence of abdominal pain, nausea, or vomiting

Duration of use

  • This product should not be used for a period longer than one week unless directed by a doctor

Change in bowel habits

  • If a sudden change in bowel habits persists for more than 2 weeks, a doctor should be consulted before using the enema

Rectal bleeding and bowel movement failure

  • Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition. Use should be discontinued and a doctor consulted

Excipient precautions

  • Care should be taken when administering preparations containing sorbitol to patients with impaired kidney function or severe liver damage

Adult dosage (ZA)

Forms avail. in SA and covered in this monograph: ene

South African registered indications and dosages

Relief of occasional constipation and for use as a bowel cleansing regimen in preparation for X-ray examination and rectoscopy

Sodium Citrate/ Sodium Lauryl Sulphoacetate 70%/ Sorbitol
90/12.9/893 (mg/ml)

  • Rectal (ene): 5ml (contents of one tube), with the nozzle inserted completely into the rectum; Desired effect usually occurs within 5-15mins

Directions for use
Twist and pull the seal off the nozzle. Squeeze the tube slightly so that a drop appears at the tip in order to provide lubrication for easier insertion. In adults insert the nozzle completely into the rectum. Empty the entire contents of the tube into the rectum by squeezing the shoulder of the tube. Withdraw the nozzle whilst keeping the tube completely compressed

Paediatric dosage (ZA)

Paed. forms avail. in SA and covered in this monograph: ene

South African registered indications and dosages

Relief of occasional constipation and for use as a bowel cleansing regimen in preparation for X-ray examination and rectoscopy

Sodium Citrate/ Sodium Lauryl Sulphoacetate 70%/ Sorbitol
90/12.9/893 (mg/ml)

  • Rectal (ene): 5ml (contents of one tube), inserted into the rectum; Desired effect usually occurs within 5-15mins

Directions for use
Twist and pull the seal off the nozzle. Squeeze the tube slightly so that a drop appears at the tip in order to provide lubrication for easier insertion. Note: for children under 3 years of age only half the length of the nozzle should be inserted into the rectum (as indicated on the nozzle). Empty the entire contents of the tube into the rectum by squeezing the shoulder of the tube. Withdraw the nozzle whilst keeping the tube completely compressed

Pregnancy & lactation

Pregnancy

South African recommendations

  • Caution; no information available

Breastfeeding

South African recommendations

  • Caution; no information available

Fertility

South African recommendations

  • No information available

Renal impairment

South African recommendations

  • Caution; no dose adjustment recommended
    Care should be taken when administering preparations containing sorbitol to patients with impaired kidney function

Hepatic impairment

South African recommendations

  • Mild to moderate: No information available
  • Severe: Caution; no dose adjustment recommended
    Care should be taken when administering preparations containing sorbitol to patients with severe liver damage

Elderly

South African recommendations

  • Caution; no information available

Adverse reactions

Gastrointestinal Disorders

Occasional

  • Rectal burning sensation

Immune System Disorders

Frequency not known

  • Hypersensitivity (general skin reaction with or without hypotension or respiratory distress)

Interactions

No information available

Monitoring

None routine

Mechanism of action

Sodium Citrate/ Sodium Lauryl Sulphoacetate/ Sorbitol attracts water into the faecal mass, thus producing a soft motion which may be easily evacuated.

Dosage forms

  • Enema

Formulation

Sodium Citrate/ Sodium Lauryl Sulphoacetate 70%/ Sorbitol

Enema (per ml) 90mg/ 12.9mg/ 893mg

References

1. PI - Microlax PI SAHPRA - Johnson & Johnson (Pty) Ltd - Date of publication - December 1995 - Received from Pharma 12 May 2025.pdf [https://medsinfoportal.sahpra.org.za/pi/35a76671183d67a68bf445905eb579c5.pdf] 2. SAIDS - Medication Check - Drug Free Sport - Microlax enema - Downloaded online 12 May 2025.pdf [https://drugfreesport.org.za/online-medication-check/] 3. NAPOS - A06AG11 - Sodium lauryl solfoacetate incl combinations - NP - Downloaded online 12 May 2025.pdf [https://drugs-porphyria.org/monograph/335/A06AG11] * No SmPC checked 12 May 2025 * No U2D checked 12 May 2025

Brands & products

0 products · cached snapshot
Trade names (2)
  • Microlax
  • Microlax Microenema

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Cited in 1 document

NeoHealth® ID 37965 · updated 10/6/2025